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Abstract
The proton pumping Hþ-ATPase, Pma1, is one of the most abundant integral membrane proteins of the yeast plasma membrane. Pma1
activity controls the intracellular pH and maintains the electrochemical gradient across the plasma membrane, two essential cellular functions.
The maintenance of the proton gradient, on the other hand, also requires a specialized lipid composition of this membrane. The plasma mem-
brane of eukaryotic cells is typically rich in sphingolipids and sterols. These two lipids condense to form less ﬂuid membrane microdomains or
lipid rafts. The yeast sphingolipid is peculiar in that it invariably contains a saturated very long-chain fatty acid with 26 carbon atoms. During
cell growth and plasma membrane expansion, both C26-containing sphingolipids and Pma1 are ﬁrst synthesized in the endoplasmatic reticulum
from where they are transported by the secretory pathway to the cell surface. Remarkably, shortening the C26 fatty acid to a C22 fatty acid by
mutations in the fatty acid elongation complex impairs raft association of newly synthesized Pma1 and induces rapid degradation of the ATPase by
rerouting the enzyme from the plasma membrane to the vacuole, the fungal equivalent of the lysosome. Here, we review the role of lipids
in mediating raft association and stable surface transport of the newly synthesized ATPase, and discuss a model, in which the newly syn-
thesized ATPase assembles into a membrane environment that is enriched in C26-containing lipids already in the endoplasmatic reticulum.
The resulting proteinelipid complex is then transported and sorted as an entity to the plasma membrane. Failure to successfully assemble
this lipideprotein complex results in mistargeting of the protein to the vacuole.
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1. Introduction
The plasma membrane constitutes the interface of the cell
with its environment. This membrane thus protects the cell
against a potential harsh and hostile environment. At the same
time, nutrient transporters located at the plasma membrane
must allow controlled uptake of small molecules and essential
cofactors that may be present in that environment. The action
of these transporters relies on an electrochemical gradient across
themembrane,which ismaintained by abundant ion pumps such
as the Naþ/Kþ-ATPase in mammalian cells or the proton
pumping Hþ-ATPase in yeast. Efﬁcient maintenance of the re-
sulting electrochemical gradient, however, requires specialized
lipids in that membrane, particularly sterols and sphingolipids.
These two lipids form condensed complexes that aggregate
into membrane microdomains or lipid rafts, which may not
only locally increase the permeability barrier of the membrane,
but also play more direct roles in protein and membrane sorting
along the exocytic and endocytic pathways. The fact that the
plasma membrane grows and expands through the biogenesis
of its components, that is both lipids and integralmembrane pro-
teins, in the endoplasmatic reticulum (ER), suggests that bio-
genesis and surface transport of proteins and lipids may be
coupled. Evidence for such a coupling between protein, lipid
biogenesis, and transport, however, is rare.
Here, we review recent results that indicate an important
role of lipids in oligomerization, raft association, and surface
Abbreviations: COPII, coat protein complex II; ER, endoplasmatic reticu-
lum; GPI, glycosylphosphatidylinositol; PI, phosphatidylinositol.
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transport of the proton pumping ATPase in Saccharomyces
cerevisiae and discuss a model in which the newly translocated
protein acquires a lipid microenvironment that corresponds to
that of its future host membrane already in the ER. In such
a model, Pma1 is then transported together with its ‘‘lipid
shell’’ enriched in C26-containing lipids to the plasma mem-
brane where it can stably integrate only if its lipid shell has
been properly formed prior to its arrival at the plasma
membrane.
2. Biogenesis and transport of the proton
pumping HD-ATPase
The proton pumping Hþ-ATPase, Pma1, belongs to the
P-type of cation transporting ATPases, which includes the
Naþ/Kþ-ATPase and Ca2þ-ATPase of the mammalian plasma
membrane [1]. A characteristic feature of P-type ATPases is
that a strictly conserved aspartate residue is phosphorylated
during the reaction cycle. Pma1 is a 100-kDa abundant and
long-lived polytopic membrane protein of the yeast plasma
membrane. Its activity is essential for regulating intracellular
pH and for uptake of nutrients by plasma membrane symport-
ers. Due to its abundance at the cell surface, where Pma1 ac-
counts for more than 25% of all the proteins, the protein
constitutes a major cargo of the secretory pathway. Thus
Pma1 serves as an excellent model to study plasma membrane
biogenesis, that is the coordinated synthesis, assembly and
transport of both the protein and lipid constituents of the future
plasma membrane.
As with other integral membrane proteins destined for the
plasma membrane, Pma1 is biosynthetically inserted into the
membrane of the ER, from where it is transported by vesicular
carriers to its ﬁnal destination [2,3]. Already in the ER, Pma1
forms a large 1.8-MDa homo-oligomeric complex that resists
extraction by detergents [4]. This proteinelipid complex is
then packaged into a larger subclass of COPII (coat protein
complex II) transport vesicles that contain both Sec24 and
its homologue, Lst1 as coat components [5]. Even though
LST1 is not essential, cells lacking LST1 are sensitive to low
pH because of a reduced ﬂux of Pma1 out of the ER [5]. Dur-
ing transport, Pma1 is not modiﬁed by glycosylation or prote-
olysis, but the protein becomes phosphorylated on multiple
serine and threonine residues [2,3]. The signiﬁcance of these
phosphorylations is still unknown, but there is evidence that
at least one of these phosphorylations that occurs at or near
the plasma membrane is important for glucose-dependent
activation of the enzyme [3,6].
From the Golgi complex, Pma1 is transported to the cell
surface by a branch of the secretory pathway that does not in-
tersect with endosomes [7,8]. At the cell surface, Pma1 be-
comes stabilized by a poorly characterized mechanism and
occupies detergent-resistant domains that are distinct from
those occupied by the arginine/Hþ symporter Can1 [9,10].
From the plasma membrane, Pma1 is ﬁnally recycled and
turned-over by endocytic delivery to the vacuole.
Because of its importance for cell viability, Pma1 is subject
to extensive studies aimed at understanding its mechanism of
action as well as its potential as a drug target for antifungal
agents. Numerous mutants that affect its catalytic activity,
quality control in the ER and/or trafﬁcking to the cell surface
have been generated and characterized [11,12].
Two of these mutants are of special interest as they affect
the stability, targeting, and detergent solubility of the mutant
enzyme during its transport to the surface. The ﬁrst of these,
Pma1-7 is a temperature-sensitive mutant allele of Pma1 that
is mistargeted from the Golgi to the vacuole under non-per-
missive conditions without reaching the cell surface [13].
Increasing the residence time of Pma1-7 in the ER, as is the
case in mutants lacking the ER membrane protein Sop4, par-
tially restores cell surface delivery of the mutant ATPase
[14]. The molecular function of Sop4, however, remains to
be established. At the Golgi apparatus, sorting of Pma1-7 is
controlled by a ubiquitin-dependent quality control system
composed of an ubiquitin ligase complex containing Rsp5
and Bul1,2 [15]. From the Golgi, rerouting of the mutant
Pma1-7 to the cell surface is restored upon inactivation of
the biosynthetic pathway to the vacuole or by sorting defects
within the endosomal system [16,17]. Interestingly, surface
delivery of Pma1-7 can also be restored by overexpression
of Ast1 a peripheral membrane protein that directly interacts
with Pma1 and induces clustering of Pma1-7 into SDS/Triton
X-100 resistant oligomers [13,18].
The second ATPase allele, Pma1-10, is also temperature-
sensitive, but in this case, the mutant protein follows the secre-
tory pathway to the cell surface but fails to become stabilized
there. Instead, it is endocytosed in an ubiquitin-dependent
manner and delivered to the vacuole for degradation. Pma1-
10 is hypophosphorylated and fails to associate with detergent
insoluble domains at the non-permissive temperature. Indicat-
ing that phosphorylation and lipid raft association may play
important roles in maintaining protein stability at the plasma
membrane [19,20]. This view is consistent with the fact that
disruption of membrane microdomains at the plasma mem-
brane by incubation with the anti-cancer drug edelfosine, an
alkylglycerophosphocholine, disrupts raft association of
plasma membrane localized Pma1 and induces its vacuolar
turnover [21].
3. Coupling of HD-ATPase biogenesis to sphingolipid
synthesis
Similar to the synthesis of integral membrane proteins, the
synthesis of sphingolipids commences in the ER, where serine
palmitoyltransferase catalyzes the condensation of serine with
palmitoyl-CoA to form a long-chain base. The long-chain base
then condenses with a C26 very long-chain fatty acid to form
ceramide, a reaction that is catalyzed by the ER localized ce-
ramide synthase. From the ER, ceramide is transported both
by vesicular and non-vesicular routes to the Golgi apparatus,
where it is converted to sphingolipids [22,23]. Mature sphin-
golipids are then transported to the plasma membrane, where
they are highly enriched [24,25] (Fig. 1).
Work by the Schekman and Chang laboratories has estab-











sphingolipid synthesis. Using either a temperature-sensitive al-
lele of serine palmitoyltransferase, lcb1-100, or myriocin to
block serine palmitoyltransferase activity, these groups
showed that ongoing long-chain base synthesis is required
for oligomerization of Pma1 in the ER membrane and for its
association with lipid rafts [4]. In the absence of long-chain
base synthesis, monomeric, non-raft associated Pma1 is still
exported from the ER but it is mistargeted to the vacuole
and degraded [4,18]. Inhibition of the conversion of ceramide
to sphingolipids by the use of aureobasidin A, an inhibitor of
phosphatidylinositol:ceramide phosphoinositol transferase
(IPC synthase, encoded by AUR1), however, does not affect
Pma1 oligomerization, indicating that long-chain base or ce-
ramide synthesis, but not sphingolipid synthesis per se, is re-
quired for oligomerization of Pma1 [4]. The formation of an
oligomeric complex in the ER is consistent with the fact that
co-expression of dominant-negative mutant forms of Pma1 re-
sults in the retention of both the mutant and the wild-type pro-
teins in the ER [26]. Formation of mixed oligomers between
the normal and mutant proteins could lead to the recognition
of the entire complex as misfolded and subject to ER quality
control. Such a model is supported by the observation that
assembly of the multimeric Pma1 complex is dependent on
long-chain base synthesis and that a block in long-chain
base synthesis relieves the dominant lethal phenotype of
a Pma1 mutant [27].
We became interested in the role of lipids in surface trans-
port of Pma1 because we observed that Pma1 was rapidly de-
graded in cells that fail to elongate the ceramide-bound C22
fatty acid to the mature C26 very long-chain fatty acid, as is
the case in cells lacking ELO3, a component of the ER local-
ized acyl chain elongase [28,29]. Interestingly, this rapid turn-
over of Pma1 in the elo3D mutant correlates with a lack of the
newly synthesized protein to acquire detergent resistance [29]
(Fig. 2). Turnover of Pma1 in elo3D is dependent on ongoing
endocytosis, indicating that the protein reaches the plasma
membrane ﬁrst, but that it fails to become stabilized there
and instead is endocytosed and delivered to the vacuole for
degradation [29]. Thus the wild-type ATPase in the elo3D mu-
tant background behaves similarly as the conditional Pma1-10
allele with regard to its increased turnover that correlates with
a failure to acquire detergent resistance [19].
Interestingly, elo3D mutant cells also affect the biogenesis
of the two populations of post-Golgi vesicles. In wild-type
cells these two vesicle populations have different densities.
The high-density vesicles contain invertase and acid phospha-
tase and intersect with the endosomal system, whereas the
low-density vesicles contain Pma1 and glucanase and are di-
rectly transported to the cell surface without intersection
with endosomes [7]. Elongase mutants on the other hand fail
to generate these two vesicle populations and instead missort
invertase and acid phosphatase into the Pma1 containing
Fig. 1. Structure of yeast sphingolipids and outline of the sphingolipid biosynthetic pathway. (A) Structure of the yeast sphingolipid. The long-chain base is marked
in pink with the amide-bound C26 fatty acid in green. The hydrophilic head group is marked in yellow. Ceramide and the three major sphingolipids, inositolphos-
phatidylceramide (IPC), mannosyl-inositolphosphatidylceramide (MIPC), and mannosyl-diinositolphosphatidylceramide (M(IP)2C) are indicated to the right. (B)
Schematic diagram of the sphingolipid pathway. Inhibitory drugs are indicated in red. See the reviews cited in the text for further details. Abbreviations are: myr,











vesicle [30]. Whether the stability of Pma1, once delivered to
the plasma membrane, is affected by the mixing of the two
vesicle populations is presently not known.
More precise analysis of the requirement for sphingolipids
in surface transport and stabilization of Pma1 then revealed
that all mutations that affect C26 synthesis result in rapid turn-
over of newly synthesized Pma1 [31]. Increased turnover of
Pma1 in these mutants is always accompanied by a lack of
the newly synthesized protein to acquire detergent resistance
[31]. Remarkably other mutations that affect the structure of
the sphingolipid head group or its hydroxylation pattern did
not affect rafts association or turnover of Pma1 [31]. These re-
sults thus suggested that the synthesis of C26-containing lipids
rather than ceramide or sphingolipids per se are important for
stable delivery of newly synthesized Pma1 to the cell surface
and for its raft association. To test this hypothesis, we took ad-
vantage of a strain that is viable even without synthesizing
long-chain base or ceramide and sphingolipids [32]. This
so-called ‘‘suppressor strain’’, bears a dominant mutation in
an acyltransferase, Slc1, that allows the enzyme to synthesize
unusual C26-containing phosphatidylinositol (PI) species.
These C26-containing PIs thus replace the essential function
of sphingolipids and structurally and functionally mimic
sphingolipids [33]. Remarkably, analysis of Pma1 stability in
this suppressor strain revealed that newly synthesized ATPase
is stably delivered to the cell surface and that it acquires deter-
gent resistance [34]. Shortening the C26 fatty acid on these
suppressor lipids by means of an elo3D mutation, however,
neutralized the suppressor activity of these lipids, resulting
in the rapid turnover of Pma1 and the newly synthesized
Pma1 failed to acquire detergent resistance [34]. These results
thus strongly indicate that lipids containing C26 fatty acids, ei-
ther ceramide or glycerophospholipid bound are important for
stable biogenesis and raft association of Pma1.
Sphingolipids associate with sterols to form membrane do-
mains that resist detergent extraction [35]. To test whether
synthesis of the fungal sterol, ergosterol, is important for
Pma1 biogenesis and acquisition of detergent resistance, the
stability of newly synthesized Pma1 was examined in viable
mutants in the post-squalene part of the ergosterol biosynthetic
pathway. Pulseechase analysis revealed that Pma1 was stable
in all the viable mutants that affect ergosterol biosynthesis.
Even a total block of the ergosterol synthesis induced by ter-
binaﬁne, an inhibitor of squalene epoxidase, did not affect
the stability of newly made Pma1 [31]. These results thus sug-
gest that the lipid microdomains that Pma1 acquires to resist
detergent extraction do not need ergosterol for their formation
and hence are distinct from the classical sterol- and sphingoli-
pid-rich domains that are known from mammalian cells [35].
This notion is further supported by the observation that the ce-
ramide backbone on the yeast sphingolipids is dispensable for
the function of sphingolipids in Pma1 biogenesis since Pma1
is stable in cells synthesizing C26-containing suppressor lipids
instead of ceramide and sphingolipids. On the other hand, ge-
netic interactions between mutations in ELO3 and defects in
certain sterol modiﬁcations, indicate that in vivo, sphingoli-
pidesterol interactions are affected by the C26 acyl chain on
the sphingolipid [29].
4. What is the function of C26-containing lipids?
C26-containing lipids are a hallmark of the yeast plasma
membrane. Synthesis of these lipids, however, occurs in the
ER where both the fatty acid elongase and the ceramide syn-
thase are located. Thus, similar to the integral membrane pro-
teins that are destined to the cell surface, C26-containing
ceramide/sphingolipids must travel from the ER to the plasma
membrane. The fact that these lipids affect detergent solubility
of newly synthesized Pma1 already upon ER exit would
indicate that lipids and protein may already assemble at their
site of synthesis and are then co-transported to the surface
[4]. A failure to properly assemble this proteinelipid complex
results either in a diversion of surface destined vesicle to the
Fig. 2. C26 fatty acids are required for biogenesis of Pma1. (A) Newly synthe-
sized Pma1 is rapidly degraded in elo3D. Pulseechase analysis of the stability
of Pma1 in wild-type (WT) and elongase (elo3D) mutant cells. Cells were cul-
tivated at 24 C, shifted to 37 C for 15 min prior to pulse-labeling and immu-
noprecipitation of Pma1p. (B) Newly synthesized Pma1 fails to acquire
detergent resistance in elo3D. Association of newly synthesized Pma1p with
lipid rafts was examined by a pulseechase experiment, in which samples
(T, total) taken at 5 or 20 min after addition of chase are extracted with Triton
X-100 and separated into a soluble (S) and detergent insoluble (P) fraction. (C)
Pma1 is mistargeted to the vacuole in elo3D. Cells expressing functional GFP-
tagged version of Pma1 were cultivated at 24 C, and then incubated at 37 C











vacuole, a failure in stabilization of the complex upon arrival
at the plasma membrane, or both [18,19,27].
Our observations would indicate that C26-containing lipids
are essential for the formation of functional lipideprotein
complexes. The precise function that C26 fulﬁlls in this as-
sembly, however, remains to be deﬁned. It has been suggested
that the length of the transmembrane domain of proteins along
the secretory pathway may increase to match bilayers of in-
creasing ‘‘thickness’’ [23]. In such a model, the abundance
of C26-containing lipids may determine the thickness of mem-
branes along the secretory pathway and thereby affect the sort-
ing of integral membrane proteins. Biophysical studies with
pure lipid bilayers, on the other hand, indicate that lipids
with highly asymmetric acyl chains can interdigitate into the
hydrophobic core of the opposite half of the bilayer and thus
do not necessarily increase the thickness of the bilayer [36].
In addition, membrane proteins themselves have recently
been shown to modulate bilayer thickness by more than 10%
[37], and observation that is consistent with the proposition
that the thickness of the lipid component of a biological mem-
brane must not naturally match that of the embedded proteins
[38]. Based on these considerations, we believe it is premature
to correlate acyl chain length with bilayer thickness in biolog-
ical membranes. Alternative functions of the C26 acyl chains
could be to interdigitate into the opposite leaﬂet thereby (i)
coupling the two halves of the bilayer to lower the energy re-
quired to deform this potentially stiff cholesterol-rich mem-
brane and (ii) increase acyl chain packing density to prevent
permeability by small molecules.
Better understanding of the role that these asymmetrical
C26-containing lipids have on protein sorting to the plasma
membrane is important because elo3D mutant cells not only
affect Pma1 stability but also show delayed ER to Golgi trans-
port of the GPI-anchored protein Gas1 and defective surface
transport of an artiﬁcial cargo protein [30,39]. We have previ-
ously characterized the biophysical properties of an inositol
glycerophospholipid with a C26 fatty acid in position sn-1
and shown that this lipid is very potent in stabilizing highly
curved membrane structures [40]. Even though we currently
do not know whether a phosphatidylinositol with a C26 acyl
chain in position sn-2, as made in strains producing the
C26-containing suppressor lipids, or a C26-containing ceram-
ide would exhibit similar biophysical properties, it is tempting
to speculate that the effect on membrane curvature is a general
property of these highly asymmetrical lipids. One of the essen-
tial functions these lipids may fulﬁll could thus be to stabilize
highly curved membrane domains that are transiently formed
during vesicle budding and fusion along the secretory path-
way. Biophysical experiments to compare the properties of
such highly asymmetric lipids will hopefully be instructive
to better deﬁne the function of these lipids in vivo.
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